Top of page

Capital Markets

Practice

Filters

CureVac $245.3 million IPO

Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which…

Flex $575 million notes reopening

Davis Polk advised the joint book-running managers in connection with a $575 million SEC-registered debt offering by…

Visa $3.25 billion notes offering

Davis Polk advised Visa Inc. on its SEC-registered offering of $500 million of 0.750% senior notes due 2027, $1 billion of 1…
Back to top